why choose us

First received: December 14, 2022

Clinical Trial: Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: End Stage Renal Disease on Dialysis

Study Type: INTERVENTIONAL


Official Title: Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease

Brief Summary: The main purpose of the study is to determine if empagliflozin can reduce peritoneal glucose absorption in patients with end stage renal diease (ESRD) on peritoneal dialysis.This is a randomized, placebo controlled, acute crossover study of empagliflozin in an anticipated 30 chronic PD patients, with an 8 week "pre post" open label extension in all 30 patients where they will receive empagliflozin daily.

Read more